"Sales of the new Voltaren Gel, which is used to treat joint pain, will start in the September quarter this year, and is likely to net Phosphagenics $5 million to $6 million a year."
I wonder if that is worldwide or just India?
A lot of self managed super fundies use Eureka Report.
I wonder if they are brave enough?
Read more at Eureka Report: http://www.eurekareport.com.au/article/2013/5/29/small-caps/three-small-caps-facing-game-changing-year#ixzz2UgkDXpXs
"Sales of the new Voltaren Gel, which is used to treat joint...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $33 | 10.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 99962608 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 53831289 | 11 |
View Market Depth
| Last trade - 13.14pm 17/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |